Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

Long-term MI Risk Among Stable CAD Patients: Some Clues From CORONOR

Shelley Wood

April 24, 2017

News Daily News

在2项新的研究中均有挥之不去的PPI的潜在心血管风险

June 18, 2015

News Daily News

Possible Cardiovascular Risk of PPIs Lingers in 2 New Studies

June 18, 2015

News Daily News

El Posible Riesgo Cardiovascular de los IBP se Mantiene en 2 Nuevos Estudios

June 18, 2015

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

L.A. McKeown

March 27, 2014

News Daily News

Meta Análisis: La Alta Reactividad Plaquetaria se asocia a un Mayor Riesgo de ACV tras PCI

L.A. McKeown

March 27, 2014

Presentation TCT 2013

TRILOGY-ACS Recap and Emerging Data: Implications for Current Prasugrel Use

Presenter: E. Magnus Ohman

October 31, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Daily News

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

July 25, 2013

News Daily News

PARADOX Published: Smokers’ Paradox Seen with Clopidogrel But not Prasugrel

Caitlin E. Cox

May 13, 2013

News Daily News

Un Estudio Avala ½ Dosis de Prasugrel en Pacientes de Poco Peso con EAC

October 18, 2012

News Daily News

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

October 18, 2012

Presentation ESC 2012

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Presenter: Matthew Roe

August 28, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Daily News

Las Directrices Elevan el Ticagrelor a la Categoría de Antiplaquetario de 1ª Línea contra la Angina Inestable

Jason Kahn

July 17, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

News Daily News

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

L.A. McKeown

March 15, 2011

Advertisement

Long-term MI Risk Among Stable CAD Patients: Some Clues From CORONOR

在2项新的研究中均有挥之不去的PPI的潜在心血管风险

Possible Cardiovascular Risk of PPIs Lingers in 2 New Studies

El Posible Riesgo Cardiovascular de los IBP se Mantiene en 2 Nuevos Estudios

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

Meta Análisis: La Alta Reactividad Plaquetaria se asocia a un Mayor Riesgo de ACV tras PCI

TRILOGY-ACS Recap and Emerging Data: Implications for Current Prasugrel Use

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

PARADOX Published: Smokers’ Paradox Seen with Clopidogrel But not Prasugrel

Un Estudio Avala ½ Dosis de Prasugrel en Pacientes de Poco Peso con EAC

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

Las Directrices Elevan el Ticagrelor a la Categoría de Antiplaquetario de 1ª Línea contra la Angina Inestable

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content